GV20 Therapeutics Joins NVIDIA Inception to Develop AI Models for Drug and Target Discovery ...Middle East

PR Newswire - Economy
GV20 Therapeutics Joins NVIDIA Inception to Develop AI Models for Drug and Target Discovery
CAMBRIDGE, Mass., March 12, 2024 /PRNewswire/ -- GV20 Therapeutics, a clinical stage biotechnology company integrating AI, genomics, and disease biology to create next-generation antibody therapeutics for cancer, announced today that it has joined NVIDIA Inception, a program that nurtures...

Hence then, the article about gv20 therapeutics joins nvidia inception to develop ai models for drug and target discovery was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GV20 Therapeutics Joins NVIDIA Inception to Develop AI Models for Drug and Target Discovery )

Apple Storegoogle play

Last updated :

Also on site :



Latest News